Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Allergan plc announced that the New Drug Application (NDA) filing for oxymetazoline HCl cream 1.0%,...
Rituximab regulatory submission accepted by European Medicines
Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one...
Anti-Cancer Agent vastin ,Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer
Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health,...
Astellas Pharma Inc , Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker...
Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated...
CHAMPIX European Union Label Updated To Include New Safety And Efficacy Data From The...
Pfizer Inc announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for...
Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented...
Aims to identify maladaptive brain circuits to find new approaches for treating psychiatric diseases...
Gather China & World Pharmaceutical Entrepreneurs,Create a New Chapter of Chinese Pharma Industry
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23,...
Kyowa Hakko Kirin Announces Commencement of Phase 2 Clinical Study of RTA 402 in...
Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a...
Mylan NV Launches First Generic Doryx Delayed-Release Tablets, 200 mg
Mylan N.V. announced the U.S. launch of Doxycycline Hyclate Delayed-Release (DR) Tablets USP, 200 mg,...
Allergan Launches IBS-D on Tract, New Online Resource to Support Patients with Irritable Bowel...
IBSDonTract.com provides clear information, symptom management strategies and interactive tools for people with IBS-D, which...
